Due to the high affinity and intestinal targeting of GCA with the apical sodium-dependent bile acid transporter (ASBT), it significantly improves drug bioavailability, anti-tumor effects, and chemotherapeutic efficacy. Here, SLC10A2 is linked to neoplasm.